Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

诉讼和私人律师事务所

P Calloway, P Noone, P Fisher

    Lancet (London, England)
    |July 23, 1988
    PubMed
    概括

    No abstract available in PubMed .

    相关实验视频

    相关概念视频

    您也可能阅读

    相关文章

    通过共同作者、期刊和引用图与本文相关的文章。

    排序
    Same author

    Evaluation of the UK's COVID-19 public health policy "Shielding: Results of a linked data matched cohort study.

    Public health·2025
    Same author

    Domain general frontoparietal regions show modality-dependent coding of auditory and visual rules.

    bioRxiv : the preprint server for biology·2024
    Same author

    3D Capsule Networks for Brain Image Segmentation.

    AJNR. American journal of neuroradiology·2023
    Same author

    Did the UK's public health shielding policy protect the clinically extremely vulnerable during the COVID-19 pandemic in Wales? Results of EVITE Immunity, a linked data retrospective study.

    Public health·2023
    Same author

    Realist analysis of whether emergency departments with primary care services generate 'provider-induced demand'.

    BMC emergency medicine·2022
    Same author

    Determination of Dabigatran Concentration in Human Plasma and Breast Milk.

    International journal of analytical chemistry·2021
    Same journal

    Metabolic traits in obesity and normal BMI in industrialised countries: a multi-country analysis of national population-based studies.

    Lancet (London, England)·2026
    Same journal

    Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

    Lancet (London, England)·2026
    Same journal

    Efficacy and safety of tirofiban after successful endovascular reperfusion in acute ischaemic stroke (ATTRACTION) in China: a multicentre, double-blind, randomised controlled trial.

    Lancet (London, England)·2026
    查看所有相关文章